89
Participants
Start Date
October 27, 2014
Primary Completion Date
June 11, 2018
Study Completion Date
December 18, 2018
CC-486
Arm 1: Two 150-mg tablets of CC-486 on Day 1 and 1 x 300 mg CC-486 on Day 2 Arm 2: 1 x 300mg tablet of CC 486 on Day 1 and 2 x 150mg CC-486 on Day 2
Vidaza
75mg/m\^2 IV or SC daily x 7 days every 4 weeks for ≤ 6 (four-week) cycles
Greenville Hospital System, Greenville
Cleveland Clinic Foundation, Cleveland
University of Iowa, Iowa City
The Methodist Hospital Research Institute l, Houston
Scottsdale Healthcare Research Institute, Scottsdale
Mayo Clinic - Arizona, Scottsdale
University of Arizona Cancer Center, Tucson
Henry Ford Health System, Detroit
Cancer Institute of New Jersey, New Brunswick
Vanderbilt- Ingram Cancer Center, Nashville
Lead Sponsor
Celgene
INDUSTRY